Showing posts with label Stem Cells Industry. Show all posts
Showing posts with label Stem Cells Industry. Show all posts

What are the Latest Advancements in the Competitive Landscape of the Stem Cells Industry?

Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

The global Stem Cells Industry is expanding at a significant CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc.

Grand View Research’s Stem Cells Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview.

Access the Global Stem Cells Industry Data Book, 2023 to 2030, compiled with details like market sizing information & forecasts, trade data, pricing intelligence, competitive benchmarking, macro-environmental analyses, and regulatory & technological framework studies

Mesenchymal Stem Cell Market Growth & Trends

The global mesenchymal stem cells market size is expected to reach USD 7.21 billion by 2030. The market is expected to reach at a CAGR of 11.4% from 2023 to 2030. An exponential increase in Mesenchymal Stem Cell (MSC) based research and its implications in the field of regenerative medicine is anticipated to fuel the industry expansion. Moreover, the constantly evolving landscape of cell therapies is also anticipated to propel investments in the mesenchymal stem cells market space; large-scale operational firms are targeting small or emerging players with an operating strategy of acquisition to bolster their market presence.

The strong pipeline of mesenchymal stem cell-based products coupled with emerging applications of mesenchymal stem cells is anticipated to accelerate the industry growth. For instance, in 2022, the U.S.FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc. Moreover, a substantial number of companies are exploring the potential of MSCs as therapeutic regime for the management of inflammatory conditions, in turn, boosting market growth.

Market players are focused on the expansion of their offerings through extensive R&D and the formation of alliances and partnerships with other major players to sustain their market position. Owing to the recent pandemic of COVID-19, several research and academic research institutes are making focused efforts to develop a treatment regime by using mesenchymal stem cells.

Mesenchymal Stem Cells Market Size, by Source of Isolation, 2022 - 2030 (USD Million)

Order your copy of the Free Sample of “Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Cancer Stem Cells Market Growth & Trends

The global cancer stem cells market size is expected to reach USD 3.1 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 12.1% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells.

Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.

Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.

Go through the table of content of Stem Cells Industry Data Book to get a better understanding of the Coverage & Scope of the study

Competitive Landscape

Key players operating in the Stem Cells industry are:

  • Advanced Cell Technology Inc.
  • STEMCELL Technologies Inc.
  • Cellular Engineering Technologies Inc.
  • CellGenix GmbH
  • PromoCell GmbH

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter

Stem Cells Industry: Asia Pacific is Expected to Grow with The Fastest CAGR of through 2023 to 2030

Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

The global Stem Cells Industry is anticipated to increase at a significant CAGR from 2023 to 2030.

Grand View Research’s Stem Cells Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.

Stem Cells Market Insights

The global stem cells market size was valued at USD 13,266.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2030. The growing development of precision medicine, increase in the number of cell therapy production facilities and rising number of clinical trials are expected to be major driving factors of the market. Recent advances in the stem cells therapeutics and the tissue engineering hold the potential to draw the attention for treatment of several diseases. Furthermore, increasing demand for stem cells banking and rise in research activities pertaining to stem cells production, storage, and characterization are also expected to fuel the revenue growth for the market. Technological improvements in the parent and ancillary market for stem cells usage are some of the other factors that reinforce the expected growth in demand for stem cells over the forecast period.

The COVID-19 pandemic had a positive impact on the market. The application of the products in the treatment of the novel coronavirus has increased the interest of medical researchers, resulting in an increase in clinical trials. Regenerative medicine based on cellular therapies may be a treatment option for patients, resulting in a reduction in mortality and infection rates. Companies and research institutes are collaborating to develop novel treatment options for the disease. For example, Infectious Disease Research Institute and Celularity, announced in April 2020 that the US FDA had approved a clinical trial application to develop cell-based therapy for COVID-19. Hence, growing applications for clinical trials are expected to boost the demand for stem cells during the forecast period.

Order your copy of the Free Sample of “Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Cancer Stem Cells Market Share, by Cancer Forms, 2022 (%)

Cancer Stem Cells Market Insights

The global cancer stem cells market size was valued at USD 2.59 billion in 2022 and it is expected to grow at a CAGR of 12.1% over the forecast period. The increasing prevalence of cancer, increased R&D activities, and adoption of stem cells are some of the major factors driving the market. Currently, oncology therapeutics has entered a new era with conventional therapies such as radiotherapy, chemotherapy, & surgeries on one side and stem cell therapies on another side.

Over the past few years, stem cells have been successfully utilized in immuno-reconstitution and for blood replenishment after tumor development or treatment. Furthermore, these cells have gained significant attention among healthcare entities for their employment as tools for delivering anti-cancer agents and tissue regeneration. A considerable number of entities have reported positive outcomes of using this mode of tumor treatment. While this therapy is receiving huge success in clinical oncology, a substantial number of published studies have mentioned cancer as a “Cancer Stem Cell (CSC) disorder”. Due to the introduction of this novel concept, an enormous potential for anti-CSC therapeutics has been created.

This approach enables comprehensive investigation of essential and poorly understood clinical events in tumor initiation, propagation, relapse, and metastasis. This is considered one of the major factors responsible for increasing interest in the cancer stem cell model. There is accumulating evidence that sheds light on the existence of cancer stem cells and their role in conferring drug resistance. This further allows generating of novel targets to overcome therapeutic resistance by controlling the regulation of these cells. Hence, CSCs, as potential therapeutic targets, enable therapeutic development that effectively combat tumor progression.

Go through the table of content of Stem Cells Industry Data Book to get a better understanding of the Coverage & Scope of the study

Stem Cells Industry Data Book Competitive Landscape

Competitive rivalry in the stem cell industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space.

Key players operating in the Stem Cells Industry are:

  • Advanced Cell Technology Inc.
  • STEMCELL Technologies Inc.
  • Cellular Engineering Technologies Inc.
  • CellGenix GmbH
  • PromoCell GmbH

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. 

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter

Stem Cells Industry Demand is Accelerated by Rising Funds for Accelerating Stem Cell Research

Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030

Grand View Research’s Stem Cells Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research. The following data points will be included in the final product offering in five reports and one sector report overview.

Access the Global Stem Cells Industry Data Book, 2023 to 2030, compiled with details like trade data, pricing intelligence, and competitive benchmarking.

Induced Pluripotent Stem Cells Production Market Report Highlights

The global Induced Pluripotent Stem Cells Production Market size was valued at USD 1.36 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030.

  • By process, the manual iPSCs production process held the highest market share in 2021. The multiple stages involved during the manufacturing process and key companies providing the expertise for induced pluripotent stem cell production attributes to the growth
  • By workflow, in 2021, the cell culture was the highest revenue-generating segment. As cell culture is a pivotal step in the production process and the associated costs during numerous steps drive the market growth of this segment
  • By product, the consumables & kits segment held the largest market in 2021. The continuous use of these iPSCs products during various applications such as toxicology testing is propelling the segment’s growth  
  • By application, drug development and discovery dominated the induced pluripotent stem cells production marketspace in 2021. The prevalence of chronic diseases is driving the increase in innovative drug platforms for development & discovery by utilizing iPSCs as diseased models
  • By end-user, the biotechnology and pharmaceutical companies generated the highest revenue in the marketplace during 2021. The rising number of strategic initiatives, new product launches, and robust iPSCs product pipeline is attributing to the generation of revenue
  • North America region contributes to the largest share in 2021 for iPSCs production marketplace. The key factors driving the revenue growth are the developed healthcare infrastructure, the prevalence of chronic diseases, the presence of strategic business models and funds by supportive government

Order your copy of Free Sample of “Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research

Mesenchymal Stem Cells Market Report Highlights

The global Mesenchymal Stem Cells Market size was valued at USD 3.02 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2030.

  • The products segment dominated the segment and accounted for the largest revenue share of 78.8% in 2022. Among the products, the cells and cell lines segment has emerged as a key contributor to the segment’s revenue
  • Based on workflow type, the culture and cryopreservation segment dominated the industry with revenue share of 44.5% in 2022. The segment growth is attributed to the high demand for cryopreservation services and enhancement of healthcare infrastructure in developing economies
  • The allogenic MSCs segment accounted for the higher revenue share of 56.6% in 2022. This is attributed to the high safety profile of allogeneic mesenchymal stem cells in clinical applications
  • The bone marrow segment dominated the market and accounted for the largest revenue share of 24.52% in 2022. Bone marrow is a major source of isolation for mesenchymal cells
  • The disease modelling application segment dominated the application and accounted for the largest revenue share of 35.1% in 2022. The use of cellular disease models with patient specific MSCs provides an ideal tool for pathological research
  • North America dominated the market and accounted for the largest revenue share of 44.28% in 2022. The higher revenue share of the region is accounted to supportive government legislation and rising application of cell therapies in chronic disorders

Go through the table of content of Stem Cells Industry Data Book to get a better understanding of the Coverage & Scope of the study

Competitive Landscape

Competitive rivalry in the stem cell industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space. Some of the major players are STEMCELL Technologies Inc., Advanced Cell Technology Inc., Cellular Engineering Technologies Inc., CellGenix GmbH, Angel Biotechnology, PromoCell GmbH, Kite Pharma, Lonza, Cellartis AB, Celgene Corporation, Brainstorm Cell Therapeutics, Osiris Therapeutics, Genea Biocells, Waisman Biomanufacturing, Bioheart Inc., Tigenix, Caladrius Biosciences, Gamida Cell, and many more.

Key players operating in the Stem Cells industry are:

  • Advanced Cell Technology Inc.
  • STEMCELL Technologies Inc.
  • Cellular Engineering Technologies Inc.
  • CellGenix GmbH
  • PromoCell GmbH
  • Kite Pharma
  • Lonza
  • Cellartis AB
  • Angel Biotechnology
  • Brainstorm Cell Therapeutics

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
Follow Us: LinkedIn | Twitter

Urban Growth and Electricity Demand Expand the Footprint of the Protective Relay Market

Protective relays rarely make headlines, but power systems depend on them. They detect faults, isolate the affected section in milliseconds,...